MedPath

Effect of Helicobacter pyroli eradication on patient with non aclcholic fatty liver disease

Not Applicable
Conditions
non alcoholic fatty liver disease Helicobacter pylori infection
Registration Number
JPRN-UMIN000008243
Lead Sponsor
Chigasaki Municipal Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with another liver disease 2)Patients with previous hepatectomy 3)Patients with intiated or changed anitidiabetic, antidyslipidemic, antiinflammatory drugs or liver supporting therapy 4)Patients with severe infection or trauma 5)Patients with malignancy 6)Patients with gastric or duodenal ulcer in the acute phase 7)Patients druing pregnancy or lactation 8)Patients with severe liver dysfunction or renal insufficiency 9)Patients who received steroid therapy 10)Patients who were allergic to Helicobacter pylori eradication drugs 11)Patients who cann not take written informed consent 12)Patients determined to be inappropriate by phyysician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
iver dysfunction at pre and post Helicobacter pylori eradication
Secondary Outcome Measures
NameTimeMethod
ipid profile and insulin resistance at pre and post Helicobacter pylori eradication
© Copyright 2025. All Rights Reserved by MedPath